Haemophilus influenzae type b is responsible for the majority of cases of bacterial meningitis in infants and children. Other common pathogens causing bacterial meningitis include Neisseria meningitidis and Streptococcus pneumoniae. Because of the emergence of ampicillinresistant H. influenzae strains, a combination of chloramphenicol and ampicillin is currently recommended for initial treatment of bacterial meningitis (3) . Chloramphenicol is bactericidal for all three of these organisms (10) ; however, occasional resistance of H. influenzae to chloramphenicol has been reported (6, 7, 13) . In addition, chloramphenicol has potentially serious though infrequent side effects (5) . Moxalactam, a newly introduced 3-lactam agent, has appreciable in vitro and in vivo activity against H. influenzae (2, 4, 8) , and recent studies have shown excellent diffusion of moxalactam into the cerebrospinal fluid of patients with meningitis (5, 11) . Accordingly, this antibiotic may be a useful alternative to chloramphenicol in the management of patients with H. influenzae meningitis.
Here we report on the in vitro activity of moxalactam against both f-lactamase-positive and -negative H. influenzae, N. meningitidis, and S. pneumoniae. In addition, we report our findings on the interaction between moxalactam and penicillin when used together in time-kill studies with these organisms.
We used 3-lactamase-positive and -negative pneumoniae or H. influenzae as outlined above, containing moxalactam (5 ,ug/ml), penicillin G (1 ,ug/ml), and the combination of moxalactam and penicillin G (5 and 1 pug/ml, respectively).
Ten strains of each of the three species of bacteria and one strain of S. pneumoniae partially susceptible to penicillin G were used in timekill studies. The inoculum consisted of an overnight culture of bacteria in broth with approximately 109 CFU/ml. Each test sample contained 2.9 ml of broth, 1 ml of antibiotic, and 0.1 ml of inoculum. An antibiotic-free tube containing 3.9 ml of broth and 0.1 ml of inoculum served as the organism growth control. Portions of 0.1 ml were removed from the test and control tubes after 0, 4, 8, and 24 h of incubation at 370C in a candle jar atmosphere for H. influenzae; 0, 1, 2, 3, 4, 6, and 8 h for N. meningitidis; and 0, 2, 4, 6, 8 , and 24 h for S. pneumoniae. The portions were serially diluted in Mueller-Hinton broth and plated on Mueller-Hinton agar (enriched for H. influenzae and S. pneumoniae as outlined above). Colonies were counted after 24 h of incubation. Simultaneous with each series of killing studies, bacterial cell growth was followed in antibiotic-free medium. Table 1 shows the results of susceptibility tests against moxalactam and penicillin G. At the standard inoculum, moxalactam MICs and MBCs were equal to or lower than 0.1 ,ug/ml for P-lactamase-positive and -negative H. influenzae. With an inoculum of 106 to 1 CFU/ml, MICs and MBCs ranged from 3.12 to >100 ,ug/ ml, regardless of P-lactamase production.
Penicillin G, as expected, was ineffective against P-lactamase-positive H. influenzae, with MICs in excess of 100 txg/ml, but active against 3-lactamase-negative H. influenzae, with MICs of 0.3 pg/ml. When 107 CFU of H. influenzae per ml was incubated with 5 Sag of moxalactam per ml in time-kill studies, there was approximately a 3-log drop in the bacterial count after 24 h of incubation with both P-lactamase-positive and -negative H. influenzae (Fig. 1) . Penicillin G (1 pg/ml) was ineffective against 3-lactamasepositive organisms in time-kill studies but caused approximately a 3-log drop in CFU in 1B-lactamase-negative H. influenzae (Fig. 1) as moxalactam alone when incubated with 107 CFU of S. pneumoniae per ml, both causing a drop in CFU in excess of 3 logs in 8 h (Fig. 2) . The count further decreased to below detectable levels in 24 h. One strain of S. pneumoniae which was partially susceptible to penicillin G was resistant to moxalactam (Table 1) . Moxalactam alone, penicillin G alone, and the combination were all ineffective in reducing CFU of this strain in time-kill studies (Fig. 2) .
N. meningitidis was exquisitely susceptible to moxalactam, with MICs and MBCs below 0.001 ,ug/ml with a standard inoculum and 0.006 to 0.39 ,ug/ml with a heavy inoculum. In time-kill studies, all organisms were killed in 8 h of incubation with moxalactam and penicillin G alone or in combination (Fig. 3 ).
An 
